{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:18:03Z","timestamp":1790835483858,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Stony Brook Cancer Center"},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["175699"],"award-info":[{"award-number":["175699"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["181727"],"award-info":[{"award-number":["181727"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health Bridges to the Baccalaureate program","award":["R25-GM050070"],"award-info":[{"award-number":["R25-GM050070"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>New therapeutic strategies against glioblastoma multiforme (GBM) are urgently needed. Signal transducer and activator of transcription 3 (STAT3), constitutively active in many GBM tumors, plays a major role in GBM tumor growth and represents a potential therapeutic target. We have documented previously that phospho-valproic acid (MDC-1112), which inhibits STAT3 activation, possesses strong anticancer properties in multiple cancer types. In this study, we explored the anticancer efficacy of MDC-1112 in preclinical models of GBM, and evaluated its mode of action. MDC-1112 inhibited the growth of multiple human GBM cell lines in a concentration- and time-dependent manner. Normal human astrocytes were resistant to MDC-1112, indicating selectivity. In vivo, MDC-1112 reduced the growth of subcutaneous GBM xenografts in mice by up to 78.2% (P &amp;lt; 0.01), compared with the controls. Moreover, MDC-1112 extended survival in an intracranial xenograft model. Although all vehicle-treated mice died by 19 days of treatment, 7 of 11 MDC-1112-treated mice were alive and healthy by the end of 5 weeks, with many showing tumor regression. Mechanistically, MDC-1112 inhibited STAT3 phosphorylation at the serine 727 residue, but not at tyrosine 705, in vitro and in vivo. STAT3 overexpression rescued GBM cells from the cell growth inhibition by MDC-1112. In addition, MDC-1112 reduced STAT3 levels in the mitochondria and enhanced mitochondrial levels of reactive oxygen species, which triggered apoptosis. In conclusion, MDC-1112 displays strong efficacy in preclinical models of GBM, with the serine 727 residue of STAT3 being its key molecular target. MDC-1112 merits further evaluation as a drug candidate for GBM.<\/jats:p>\n               <jats:p>New therapeutic options are needed for glioblastoma. The novel agent MDC-1112 is an effective anticancer agent in multiple animal models of glioblastoma, and its mechanism of action involves the inhibition of STAT3 phosphorylation, primarily at its Serine 727 residue.<\/jats:p>","DOI":"10.1093\/carcin\/bgz069","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T03:14:21Z","timestamp":1555384461000},"page":"1480-1491","source":"Crossref","is-referenced-by-count":12,"title":["Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation"],"prefix":"10.1093","volume":"40","author":[{"given":"Dingyuan","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Nutrition, University of California, One Shields Ave, Davis, CA, USA"},{"name":"Department of Thyroid Surgery, Sun Yat-Sen University, Guangzhou, China"},{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Fraga-Lauhirat","sequence":"additional","affiliation":[{"name":"Department of Nutrition, University of California, One Shields Ave, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Millings","sequence":"additional","affiliation":[{"name":"Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristella","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Nutrition, University of California, One Shields Ave, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M","family":"Villarreal","sequence":"additional","affiliation":[{"name":"Department of Nutrition, University of California, One Shields Ave, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa C","family":"Fletchinger","sequence":"additional","affiliation":[{"name":"Department of Nutrition, University of California, One Shields Ave, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V","family":"Bonfiglio","sequence":"additional","affiliation":[{"name":"Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyda","family":"Mata","sequence":"additional","affiliation":[{"name":"Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Nemesure","sequence":"additional","affiliation":[{"name":"Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E","family":"Bartels","sequence":"additional","affiliation":[{"name":"Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Rigas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stony Brook University, Stony Brook, NY, USA"},{"name":"Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6460-7165","authenticated-orcid":false,"given":"Gerardo G","family":"Mackenzie","sequence":"additional","affiliation":[{"name":"Department of Nutrition, University of California, One Shields Ave, Davis, CA, USA"},{"name":"Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"2021031603150318500_CIT0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jocn.2018.05.002","article-title":"Ten-year survival in glioblastoma. A systematic review","volume":"54","author":"Tykocki","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"2021031603150318500_CIT0002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nec.2012.01.007","article-title":"Temozolomide and other potential agents for the treatment of glioblastoma multiforme","volume":"23","author":"Nagasawa","year":"2012","journal-title":"Neurosurg. Clin. N. Am."},{"key":"2021031603150318500_CIT0003","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2021031603150318500_CIT0004","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/cancers6041953","article-title":"The future of glioblastoma therapy: synergism of standard of care and immunotherapy","volume":"6","author":"Patel","year":"2014","journal-title":"Cancers (Basel)."},{"key":"2021031603150318500_CIT0005","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12272-016-0795-8","article-title":"Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment","volume":"39","author":"Kim","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"2021031603150318500_CIT0006","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","article-title":"Signal transducer and activator of transcription proteins in leukemias","volume":"101","author":"Benekli","year":"2003","journal-title":"Blood"},{"key":"2021031603150318500_CIT0007","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/sj.leu.2403750","article-title":"STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis","volume":"19","author":"Holtick","year":"2005","journal-title":"Leukemia"},{"key":"2021031603150318500_CIT0008","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports Ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"},{"key":"2021031603150318500_CIT0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","article-title":"Function of mitochondrial Stat3 in cellular respiration","volume":"323","author":"Wegrzyn","year":"2009","journal-title":"Science"},{"key":"2021031603150318500_CIT0010","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1586\/14737175.2014.964211","article-title":"NF-\u03baB and STAT3 in glioblastoma: therapeutic targets coming of age","volume":"14","author":"Gray","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"2021031603150318500_CIT0011","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1158\/0008-5472.CAN-14-2800","article-title":"FoxM1 drives a feed-forward STAT3-activation signaling loop that promotes the self-renewal and tumorigenicity of glioblastoma stem-like cells","volume":"75","author":"Gong","year":"2015","journal-title":"Cancer Res."},{"key":"2021031603150318500_CIT0012","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1158\/1078-0432.CCR-07-4923","article-title":"Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators","volume":"14","author":"Lo","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2021031603150318500_CIT0013","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1158\/1078-0432.CCR-08-1329","article-title":"The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas","volume":"14","author":"Abou-Ghazal","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2021031603150318500_CIT0014","first-page":"3141","article-title":"STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma","volume":"7","author":"Lin","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"2021031603150318500_CIT0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-016-2231-9","article-title":"Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo","volume":"130","author":"Han","year":"2016","journal-title":"J. Neurooncol."},{"key":"2021031603150318500_CIT0016","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cancers6010376","article-title":"STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications","volume":"6","author":"Kim","year":"2014","journal-title":"Cancers (Basel)."},{"key":"2021031603150318500_CIT0017","doi-asserted-by":"crossref","first-page":"e61532","DOI":"10.1371\/journal.pone.0061532","article-title":"Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice","volume":"8","author":"Mackenzie","year":"2013","journal-title":"PLoS One"},{"key":"2021031603150318500_CIT0018","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1158\/0008-5472.CAN-11-2349","article-title":"Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds","volume":"71","author":"Huang","year":"2011","journal-title":"Cancer Res."},{"key":"2021031603150318500_CIT0019","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/j.gastro.2010.06.044","article-title":"Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice","volume":"139","author":"Mackenzie","year":"2010","journal-title":"Gastroenterology"},{"key":"2021031603150318500_CIT0020","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1593\/neo.131368","article-title":"A novel Ras inhibitor (MDC-1016) reduces human pancreatic tumor growth in mice","volume":"15","author":"Mackenzie","year":"2013","journal-title":"Neoplasia"},{"key":"2021031603150318500_CIT0021","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"2021031603150318500_CIT0022","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1158\/0008-5472.CAN-08-2010","article-title":"The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents","volume":"68","author":"Sun","year":"2008","journal-title":"Cancer Res."},{"key":"2021031603150318500_CIT0023","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/carcin\/bgp015","article-title":"Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect","volume":"30","author":"Zhao","year":"2009","journal-title":"Carcinogenesis"},{"key":"2021031603150318500_CIT0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ijc.23477","article-title":"Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin\u2019s lymphoma cells","volume":"123","author":"Mackenzie","year":"2008","journal-title":"Int. J. Cancer"},{"key":"2021031603150318500_CIT0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/1940-6207.CAPR-11-0067","article-title":"Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice","volume":"4","author":"Mackenzie","year":"2011","journal-title":"Cancer Prev. Res. (Phila)."},{"key":"2021031603150318500_CIT0026","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7150\/ijbs.15153","article-title":"Mitochondrial Stat3, the need for design thinking","volume":"12","author":"Yang","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"2021031603150318500_CIT0027","doi-asserted-by":"crossref","first-page":"e83395","DOI":"10.1371\/journal.pone.0083395","article-title":"The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation","volume":"8","author":"Gough","year":"2013","journal-title":"PLoS One"},{"key":"2021031603150318500_CIT0028","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.bjc.6604225","article-title":"Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer","volume":"98","author":"Rigas","year":"2008","journal-title":"Br. J. Cancer"},{"key":"2021031603150318500_CIT0029","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.18632\/oncotarget.663","article-title":"Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma","volume":"3","author":"de Groot","year":"2012","journal-title":"Oncotarget"},{"key":"2021031603150318500_CIT0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/2152-7806.89886","article-title":"The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies","volume":"2","author":"Heimberger","year":"2011","journal-title":"Surg. Neurol. Int."},{"key":"2021031603150318500_CIT0031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1593\/neo.91196","article-title":"A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells","volume":"12","author":"Lin","year":"2010","journal-title":"Neoplasia"},{"key":"2021031603150318500_CIT0032","doi-asserted-by":"crossref","first-page":"31280","DOI":"10.1074\/jbc.M113.505057","article-title":"Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2021031603150318500_CIT0033","doi-asserted-by":"crossref","first-page":"e9532","DOI":"10.1371\/journal.pone.0009532","article-title":"Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro","volume":"5","author":"Sarafian","year":"2010","journal-title":"PLoS One"},{"key":"2021031603150318500_CIT0034","doi-asserted-by":"crossref","first-page":"29610","DOI":"10.1074\/jbc.M111.226209","article-title":"Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species","volume":"286","author":"Szczepanek","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021031603150318500_CIT0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mito.2011.08.011","article-title":"Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3","volume":"12","author":"Szczepanek","year":"2012","journal-title":"Mitochondrion"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgz069\/28530885\/bgz069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/40\/12\/1480\/36604734\/bgz069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/40\/12\/1480\/36604734\/bgz069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T03:15:59Z","timestamp":1615864559000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/40\/12\/1480\/5474385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,4,17]]},"published-print":{"date-parts":[[2019,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgz069","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,4,17]]}}}